Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
The Factor VII Preliminary test is a screening assay that estimates how well Factor VII, a vitamin K dependent clotting protein, is working in your blood plasma. Factor VII helps start the clotting process when blood vessels are injured and tissue factor is exposed. This test reports activity relative to a normal control to flag whether Factor VII may be lower or higher than expected.
It is commonly used as an initial check when there is an abnormal clotting screen or concern about a bleeding tendency. Abnormal screening results are typically followed by more specific testing, such as a detailed factor VII assay, mixing studies, or evaluations for inhibitors, to confirm the cause.
Understanding Factor VII activity helps explain symptoms like easy bruising, frequent nosebleeds, heavy menstrual bleeding, or unexpected bleeding during procedures. Low activity can occur with inherited Factor VII deficiency, liver disease, vitamin K deficiency, or with use of medications that reduce vitamin K activity, such as warfarin.
Clinicians may order this test when the prothrombin time is prolonged, before surgery or dental work, or during evaluation of unexplained bleeding. Results can guide treatment, including vitamin K support, medication adjustments, or specialist care for rare inherited conditions.
If your activity is lower than expected, your care team may repeat the test and review how the sample was collected, then look for causes such as recent warfarin use, limited vitamin K intake, antibiotics, liver problems, or an inherited deficiency. Follow up can include a full factor VII assay, mixing studies, liver tests, nutritional review, or a trial of vitamin K when appropriate.
If your activity is higher than expected, it is usually not concerning but may occur with pregnancy, inflammation, or use of estrogen containing medications. Your clinician will interpret the result together with your medical history, medicines, and other coagulation tests. Do not change or stop any medication without medical advice. If you have procedures planned, discuss timing and any needed precautions.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
An underfilled or overfilled blue top tube, improper mixing with citrate, or delayed processing can falsely lower activity. Prompt centrifugation and testing of properly filled tubes help ensure reliable results.
Low dietary vitamin K, poor absorption due to gut disorders, or recent broad spectrum antibiotics that reduce gut flora can lower Factor VII activity. Consistent intake supports stable results.
Warfarin and other vitamin K antagonists decrease Factor VII activity. Some antibiotics, high dose salicylates, and certain herbal products can also affect coagulation. Always list all medicines and supplements.
Factor VII is made in the liver. Liver disease or consumptive states like disseminated intravascular coagulation can reduce activity. Acute inflammation can transiently change coagulation test results.
Pregnancy and estrogen containing contraceptives or therapy can increase Factor VII activity. Your clinician will interpret results in the context of these physiologic changes.
Transfusion of plasma or use of procoagulant concentrates may transiently normalize or elevate activity. Provide timing of any recent blood products to your care team.
References